NasdaqGM:LRMR
NasdaqGM:LRMRBiotechs

Do Positive Friedreich's Ataxia Study Results Shift Larimar Therapeutics’ (LRMR) Long-Term Value Proposition?

Larimar Therapeutics recently announced positive data from its long-term open-label study evaluating daily subcutaneous injections of nomlabofusp in patients with Friedreich's Ataxia, alongside an update on its development program. This milestone highlights progress in advancing novel treatments for a rare neurological disease, capturing interest among rare disease and biotech stakeholders. We’ll explore how the encouraging clinical results for nomlabofusp are influencing Larimar...
NYSE:BKKT
NYSE:BKKTCapital Markets

Bakkt Holdings (BKKT): Evaluating the Valuation After Strategic Shift to Crypto Infrastructure and Board Reshuffle

Bakkt Holdings (BKKT) shares have soared after the company sharpened its focus on crypto custody, stablecoin payments, and treasury management. This follows the sale of its loyalty rewards business and recent board changes. See our latest analysis for Bakkt Holdings. Bakkt’s sharpened focus has breathed new life into its stock, with a notable short-term rally fueled by the shift toward digital assets and a well-received board appointment. While the 1-year total shareholder return sits at...
NYSE:NATL
NYSE:NATLDiversified Financial

Is There Still Room for NCR Atleos After 40% Rally and Positive Digital Payment Trends?

If you have NCR Atleos stock on your watchlist, you are not alone. This payment technology player has delivered a big pop in the past year, with shares climbing an impressive 40.8%. Even just in the past seven days, the stock has edged up another 1.9%, outpacing broader markets. With the year-to-date return at 15.5%, it is no wonder investors are debating whether this momentum has room to run, or if it's time to cash in. What’s behind these moves? Most of the recent excitement traces back to...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI (RZLV): Losses Worsen by 38.9% Annually Despite Strong Growth Forecasts Challenging Bull Narratives

Rezolve AI (RZLV) continues to operate at a loss, with net losses accelerating by 38.9% annually over the past five years. Despite negative equity, signaled by a deeply negative Price-To-Book Ratio of -127.6x compared to both peer and industry averages, the company’s earnings are forecast to surge 117.9% per year while revenue is expected to climb 95% annually. These projections are both well ahead of market norms. Shares currently trade at $6.28, notably below an estimated fair value of...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

Assessing Cogent Stock After 47% Fall and Projected Free Cash Flow Rebound in 2025

If you’re staring at Cogent Communications Holdings stock and asking yourself what comes next, you’re definitely not alone. After all, this is a company that has provided a wild ride for investors. In just one week, Cogent edged up by 1.3%, while over the past month it’s delivered a much punchier 9.4% gain. Still, when you zoom out, the picture gets trickier: the stock is down a stunning 47.6% year-to-date and has lost 42.3% over the past year. Even stretching the timeline further, the...
NasdaqGS:HST
NasdaqGS:HSTHotel and Resort REITs

Is There Value Left in Host Hotels After Strong Q1 Earnings and Raised Guidance for 2025?

If you are navigating the world of real estate investment trusts, chances are you are considering what to do with your Host Hotels & Resorts shares right now. You are not alone—investors across the board have been debating whether this stock is a hidden gem or one that is already reflecting its full potential. Looking at the numbers, Host Hotels & Resorts ended the most recent session at $17.11, and while the stock has dipped by 1.2% over the past week, it is holding steady for the past...
NYSE:ARIS
NYSE:ARISEnergy Services

Aris Water Solutions (ARIS): Assessing Valuation After a 45% One-Year Shareholder Return

Aris Water Solutions (ARIS) shares have climbed over the past year, returning 45% to investors. The company’s revenue and net income have both improved, and there are clear signals of ongoing business expansion. See our latest analysis for Aris Water Solutions. Momentum for Aris Water Solutions has been steady, with a 1-year total shareholder return of 45% that reflects sustained growth and renewed investor confidence. Recent results suggest that the company’s improving fundamentals are...
NasdaqGS:ANGO
NasdaqGS:ANGOMedical Equipment

Why AngioDynamics (ANGO) Is Up 10.9% After Raising Sales Guidance and Narrowing Quarterly Loss

On October 2, 2025, AngioDynamics, Inc. reported first quarter earnings, announcing sales of US$75.71 million versus US$67.49 million a year earlier and a reduced net loss of US$10.9 million compared to US$12.8 million in the previous year, alongside basic and diluted loss per share of US$0.26. The company also raised its full fiscal year 2026 sales guidance, now expecting net sales of US$308 million to US$313 million, reflecting a more optimistic outlook on financial and operational...
NYSE:JMIA
NYSE:JMIAMultiline Retail

Does Jumia Offer Real Value After Its 200% Surge and Expansion News in 2025?

Thinking about what to do with Jumia Technologies stock? You’re not alone. Lately, this once-under-the-radar e-commerce player has been turning heads with some impressive price movement. The stock jumped 7.1% just over the last week, surged 48.7% in the past month, and is up an astonishing 206.9% year-to-date. Long-term holders have also seen benefits, with gains of 115.3% in the past year and 98.2% over three years. Even the five-year return, a solid 13.8%, suggests resilience despite all...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

How Does Caris Life Sciences Stack Up After Recent 18.7% Drop?

Trying to decide what to do with Caris Life Sciences stock? You are not alone. With biotech on investors’ minds and volatility ever-present, a confident approach matters more than ever. Over the past month, Caris Life Sciences shares have slipped 18.7%, but that drawdown follows a period of growth, leaving the stock up 6.1% year-to-date. A smaller dip of just 0.1% over the last week hints that the market may be stabilizing after recent headwinds, possibly as investors process shifts in the...
NYSE:WBS
NYSE:WBSBanks

Is Webster Financial Set for More Gains After 36.5% One-Year Surge in 2025?

If you are sizing up Webster Financial right now, you are not alone. With the stock closing at $58.96 and boasting a remarkable 132.2% return over five years, many investors are wondering if it is still a smart buy or if the easy money has already been made. While there have been some recent dips, including a 1.4% decline over the past week and 5.3% for the month, the year-to-date gain stands strong at 7.6%, and the one-year return is an impressive 36.5%. These moves suggest that market...
NYSE:CBT
NYSE:CBTChemicals

Is Cabot Set for a Comeback After 30% Stock Drop and Ongoing Market Volatility?

If you find yourself wondering whether Cabot stock is a buy, hold, or sell right now, you are not alone. Over the past year, the price has certainly kept investors on their toes, dropping nearly 30% from where it stood twelve months ago. Even with that sizable slide, though, Cabot’s five-year return is an eye-popping 106.5%. This means that long-term holders have seen some remarkable gains. That mix of short-term uncertainty and long-term success makes Cabot an interesting case for anyone...
NasdaqCM:RITR
NasdaqCM:RITRReal Estate

Reitar Logtech Holdings (NasdaqCM:RITR): Evaluating Valuation Following Strategic Qatar Logistics Partnership

Reitar Logtech Holdings (NasdaqCM:RITR) has made headlines with its newly signed strategic cooperation and investment agreement with NEXX, launching a Smart Fulfillment Center project in Qatar. This move marks Reitar’s entry into the rapidly evolving Middle Eastern logistics sector. See our latest analysis for Reitar Logtech Holdings. Reitar Logtech’s leap into Qatar’s logistics scene comes at a time when its total shareholder return over the past year has dipped slightly by 0.4%. While the...
NasdaqGM:VRNA
NasdaqGM:VRNAPharmaceuticals

Is There Still Opportunity in Verona Pharma After Ohtuvayre Approval and 246% Price Surge?

If you have been watching Verona Pharma’s stock lately, you are probably wondering what to do next. With shares closing at $106.82 in the latest session, it is clear this is a company that has caught serious attention. Just look at the numbers, and you will see why: Verona Pharma is up 121.6% so far this year, and an eye-popping 246.7% over the past twelve months. But the real story goes further back, with staggering multi-year gains. Over the last three years, the stock has jumped 926.1%,...
NYSE:QD
NYSE:QDConsumer Finance

eHealth And 2 Promising Penny Stocks To Consider

As major U.S. stock indexes continue to set new records, investors are navigating a landscape that seems to defy the uncertainties of a government shutdown. In such an environment, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities for those looking beyond the market giants. Despite their historically speculative reputation, these stocks can provide a blend of affordability and growth potential when backed by solid financials, making them worthy...
NasdaqGS:DSP
NasdaqGS:DSPSoftware

How Investors Are Reacting To Viant Technology (DSP) Deepening Tubi Partnership for Advanced CTV Ad Targeting

Viant Technology recently announced an expanded partnership with Tubi, Fox Corporation's free ad-supported streaming service, featuring a robust ID sync and deeper ad server integration, which gives advertisers improved reach and accuracy across Tubi's more than 100 million monthly active users and over 300,000 movies and TV episodes. This collaboration brings IRIS.TV's contextual and emotional data technology to Tubi's library, enabling more precise, measurable, and relevant audience...
NasdaqGM:ASTL
NasdaqGM:ASTLMetals and Mining

Can Government-Backed Support Shift the Strategic Foundation of Algoma Steel Group (ASTL)?

Algoma Steel Group Inc. recently secured C$500 million in liquidity support from the Canadian and Ontario governments to address ongoing trade challenges and accelerate its business transformation, including a transition to Electric Arc Furnace steelmaking and a focus on the domestic market. This government-backed financing not only provides essential financial flexibility but also signals reinforced public support for Algoma's shift away from blast furnace operations due to U.S. tariffs,...
NYSE:KRC
NYSE:KRCOffice REITs

Should Investors Revisit Kilroy Realty After Positive Leasing Momentum in 2025?

Wondering whether to add, hold, or walk away from Kilroy Realty? You are not alone. The company's stock has been on something of a rollercoaster, falling 2.7% over the past week, but still up 2.9% for the month and impressively up 18.6% over the last year. Year-to-date performance also sits in positive territory at 5.8%. However, when you zoom out to five years, it is basically flat. What is behind these moves? Like most office-focused real estate companies, Kilroy has had to weather changing...
NasdaqGS:SLDE
NasdaqGS:SLDEInsurance

Slide Insurance Holdings (SLDE): Assessing Valuation After Recent Share Price Pullback

Slide Insurance Holdings (SLDE) shares pulled back 1% today, giving investors a chance to revisit the company’s core numbers and recent performance. Over the past month, the stock actually climbed 9%. See our latest analysis for Slide Insurance Holdings. Although Slide Insurance Holdings’ share price is still well below its highs for the year, a solid 1-month share price return signals momentum could be shifting in the company’s favor after a tougher stretch earlier in 2024. With investors...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX (SNX) Net Margin Beats Expectations, Reinforcing Value Narrative Despite Slowing Growth

TD SYNNEX (SNX) reported a net profit margin of 1.3%, up slightly from last year’s 1.2%, with earnings growing 13.5% year-over-year. This trails its five-year annual average of 15.2%. Forward-looking projections call for annual earnings growth of 7.6% and revenue growth of 4.5%, suggesting a slower pace compared to the company’s historical performance and the broader US market. With strong profit expansion and no flagged material risks, ongoing revenue and margin growth remain the key drivers...
NasdaqGS:CRTO
NasdaqGS:CRTOMedia

Does Recent Share Slide Signal Opportunity in Criteo Stock for 2025?

Wondering what to make of Criteo’s stock after a rocky few months? You are definitely not alone. Whether you are weighing a fresh position or eyeing your existing holdings, the recent numbers grab your attention. Criteo closed at $21.31, but over the last one and three years, shares have dropped a hefty 45.1% and 21.5%, respectively. Even in the past week and month, the slides have continued, with returns of -5.3% and -9.4%. Yet, despite these setbacks, the longer-term five-year return still...
NasdaqCM:MRNO
NasdaqCM:MRNOReal Estate

Murano Global Investments (MRNO) Losses Worsen 99.7% Annually, Challenging Value-Focused Narratives

Murano Global Investments (MRNO) has seen its losses accelerate at a striking rate of 99.7% per year over the past five years, with its net profit margin remaining firmly in negative territory. While the stock’s Price-to-Sales Ratio of 3.3x looks cheap compared to peer group averages of 6.9x, it remains slightly above the broader US real estate industry average of 3x. Despite appearing attractively valued on this metric, persistent unprofitability and growing losses present a cautious set of...